PL2841447T3 - Nowa kompozycja dopozaustrojowej redukcji beta-amyloidów oraz procesu ich wytwarzania - Google Patents

Nowa kompozycja dopozaustrojowej redukcji beta-amyloidów oraz procesu ich wytwarzania

Info

Publication number
PL2841447T3
PL2841447T3 PL13781268T PL13781268T PL2841447T3 PL 2841447 T3 PL2841447 T3 PL 2841447T3 PL 13781268 T PL13781268 T PL 13781268T PL 13781268 T PL13781268 T PL 13781268T PL 2841447 T3 PL2841447 T3 PL 2841447T3
Authority
PL
Poland
Prior art keywords
amyloids
beta
producing
novel composition
extracorporeal reduction
Prior art date
Application number
PL13781268T
Other languages
English (en)
Inventor
Rogelio B. SANTOS, Jr.
Stanley Stein
Chinnaswamy Kasinathan
Original Assignee
Amylex Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylex Pharmaceuticals, Inc. filed Critical Amylex Pharmaceuticals, Inc.
Publication of PL2841447T3 publication Critical patent/PL2841447T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL13781268T 2012-04-26 2013-01-30 Nowa kompozycja dopozaustrojowej redukcji beta-amyloidów oraz procesu ich wytwarzania PL2841447T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261638672P 2012-04-26 2012-04-26
PH12013000037 2013-01-30
EP13781268.1A EP2841447B1 (en) 2012-04-26 2013-01-30 Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof
PCT/PH2013/000005 WO2013162387A1 (en) 2012-04-26 2013-01-30 Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof

Publications (1)

Publication Number Publication Date
PL2841447T3 true PL2841447T3 (pl) 2019-03-29

Family

ID=49483563

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13781268T PL2841447T3 (pl) 2012-04-26 2013-01-30 Nowa kompozycja dopozaustrojowej redukcji beta-amyloidów oraz procesu ich wytwarzania

Country Status (17)

Country Link
US (1) US20150087591A1 (pl)
EP (1) EP2841447B1 (pl)
JP (1) JP2015515491A (pl)
KR (2) KR20180117226A (pl)
CN (2) CN109731169A (pl)
AU (2) AU2013253098A1 (pl)
CA (1) CA2871585A1 (pl)
DK (1) DK2841447T3 (pl)
ES (1) ES2685374T3 (pl)
HR (1) HRP20181365T1 (pl)
IN (1) IN2014MN02137A (pl)
LT (1) LT2841447T (pl)
PL (1) PL2841447T3 (pl)
RS (1) RS57651B1 (pl)
SG (1) SG11201406972UA (pl)
SI (1) SI2841447T1 (pl)
WO (1) WO2013162387A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106800590B (zh) * 2015-11-25 2021-04-09 杭州智鹤丹谷生物医药有限公司 一种结合多种淀粉样蛋白单体和聚集体的多肽及其应用
CN105651840B (zh) * 2016-04-01 2017-12-26 商丘师范学院 一种检测β‑淀粉样蛋白寡聚体的类免疫电化学传感器及其制备方法
CN109954128A (zh) * 2019-03-08 2019-07-02 南开大学 一种可干扰β-淀粉样蛋白聚集并协助清除的功能化纳米凝胶及制备方法
CN114933635B (zh) * 2021-08-29 2023-05-19 武汉夫图生物科技有限公司 纳米小肽fh及其在制备治疗及预防眼底血管疾病药物中的应用
US20230201438A1 (en) * 2021-12-23 2023-06-29 Fresenius Medical Care Holdings, Inc. Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5223199B2 (pl) * 1972-05-27 1977-06-22
JPS4942189A (pl) * 1972-08-29 1974-04-20
EP0815134B1 (en) * 1995-03-14 2002-06-05 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
JPH09157283A (ja) * 1995-12-13 1997-06-17 Tatsuaki Yamaguchi 燐酸吸着コロイド
US6022859A (en) * 1996-11-15 2000-02-08 Wisconsin Alumni Research Foundation Inhibitors of β-amyloid toxicity
AU2003303198A1 (en) * 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
US20060069010A1 (en) * 2003-10-17 2006-03-30 Senicure Llc Detoxification depot for Alzheimer's disease
US20070092508A1 (en) * 2005-10-21 2007-04-26 Recombiant Technologies, Llc Detoxification depot for Alzheimer's disease
US20130143909A1 (en) * 2009-11-18 2013-06-06 Nektar Therapeutics Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods
CN102108119A (zh) * 2009-12-25 2011-06-29 天津键凯科技有限公司 多臂聚乙二醇衍生物及其与药物的结合物和凝胶
JP5843345B2 (ja) * 2010-07-08 2016-01-13 旭化成メディカル株式会社 β−アミロイド除去システム

Also Published As

Publication number Publication date
EP2841447A4 (en) 2015-10-28
IN2014MN02137A (pl) 2015-08-21
US20150087591A1 (en) 2015-03-26
LT2841447T (lt) 2018-09-10
CN104662032A (zh) 2015-05-27
DK2841447T3 (en) 2018-09-03
SI2841447T1 (sl) 2018-10-30
EP2841447A1 (en) 2015-03-04
WO2013162387A1 (en) 2013-10-31
ES2685374T3 (es) 2018-10-08
AU2013253098A1 (en) 2014-11-13
EP2841447B1 (en) 2018-06-13
KR20150022753A (ko) 2015-03-04
CA2871585A1 (en) 2013-10-31
SG11201406972UA (en) 2014-11-27
AU2016208257B2 (en) 2018-08-16
CN109731169A (zh) 2019-05-10
KR20180117226A (ko) 2018-10-26
JP2015515491A (ja) 2015-05-28
AU2013253098A2 (en) 2015-04-30
AU2016208257A1 (en) 2016-08-11
RS57651B1 (sr) 2018-11-30
HRP20181365T1 (hr) 2018-10-19

Similar Documents

Publication Publication Date Title
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
FI2841431T4 (fi) Bentsotiofeeniyhdisteen dihydraatti ja menetelmä sen tuottamiseksi
HK1198012A1 (zh) 用於治療瘻的組合物
GB2503842B (en) Composition and method of manufacture
SG10201703051WA (en) Compounds and methods for the production of suckerin and uses thereof
HRP20181365T1 (hr) Novi sastav za izvantjelesno smanjenje beta-amiloida i postupak njegove proizvodnje
GB2503334B (en) Metal-organic framework compounds and their method of manufacture
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
SG11201406623PA (en) Process for the preparation of rivaroxaban and intermediates thereof
HRP20181931T1 (hr) Kontinuirani proces za pripravu (s)-2-acetiloksipropionske kiseline
IL236450A (en) Process for making 5-fluoro-h1-pyrazoles
PL399419A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
PL399418A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
GB201509165D0 (en) Tampon method of manufacture
EP2866757A4 (en) BUFFER MANUFACTURING METHOD
PT2841447T (pt) Composição inovadora para redução extracorpórea de beta-amiloides e processo para produção dos mesmos
HU229987B1 (en) Process for the preparation of pyrimidinyl-piperazines
HUP1100394A2 (en) Eardrop composition and process for producing this